Amneal Pharmaceuticals, INC. (AMRX) — SC 13D/A Filings

All SC 13D/A filings from Amneal Pharmaceuticals, INC.. Browse 3 SC 13D/A reports with AI-powered summaries and risk analysis.

SC 13D/A Filings (3)

Patel Amends Amneal Stake Filing — Oct 31, 2024 Risk: medium
Chirag Patel, through an amendment filed on October 31, 2024, has updated his Schedule 13D filing regarding Amneal Pharmaceuticals, Inc. The filing indicates a
Patel Amends Amneal Pharma Stake Filing — May 13, 2024 Risk: medium
On May 9, 2024, Tushar Bhikhubhai Patel filed an amendment (Amendment No. 4) to Schedule 13D for Amneal Pharmaceuticals, Inc. The filing indicates a change in b
Gautam Patel Joins Group in Amneal Pharma, Signaling Potential Activism — Jan 3, 2024
Gautam Patel, a significant shareholder in Amneal Pharmaceuticals, Inc., filed an Amendment No. 5 to his Schedule 13D on January 1, 2024. This filing indicates

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX